Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share (OTLK)

Historical Holders from Q1 2023 to Q2 2025

Symbol
OTLK on Nasdaq
CUSIP
69012T305
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
44.5M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
5.94M
Holdings value
$9.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
34
Number of sells
-33
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share (OTLK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GMS Ventures & Investments 50.3% +20.7% $45.3M $20.1M 29M +79.4% GMS VENTURES & INVESTMENTS May 27, 2025
Empery Asset Management, LP 7.57% $6.49M 3.2M Empery Asset Management, LP Jun 30, 2025
SPHERA FUNDS MANAGEMENT LTD. 7.49% +45.6% $3.55M $1.18M 2.57M +50% Sphera Funds Management Ltd. Apr 10, 2025
GREAT POINT PARTNERS LLC 4.99% -23% $2.42M 2.22M 0% Great Point Partners, LLC Jun 30, 2025
TANG CAPITAL PARTNERS LP 6.4% $2.32M 1.68M TANG CAPITAL MANAGEMENT, LLC Dec 31, 2024
TANG CAPITAL MANAGEMENT LLC 3.4% -36.7% $1.64M -$436K 1.5M -21.1% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, $0.001 par value per share (OTLK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 5.94M $9.5M -$1.3M $1.60 63
2025 Q1 7.08M $8.64M +$2.8M $1.22 61
2024 Q4 4.55M $8.59M -$17.6M $1.89 60
2024 Q3 7.93M $42.3M -$3.22M $5.34 68
2024 Q2 8.04M $59.4M +$2.23M $7.38 63
2024 Q1 7.24M $86.2M +$86M $11.94 53
2023 Q3 34.2K $7.56K $0 $0.22 1
2023 Q2 34.2K $59.5K $0 $1.74 1
2023 Q1 34.2K $37.3K +$37.3K $1.09 1